Home Compare MRNA vs SDF.DE
Stock Comparison · Comparison

Moderna vs K+S Aktiengesellschaft: Which Stock Looks Stronger in 2026?

K+S Aktiengesellschaft holds the cleaner structural position, with the lead spread across growth and stability. Moderna does not offset that deficit through any equally strong structural edge elsewhere. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both growth and stability materially support the lead. The overall score gap is 48 points in favour of K+S Aktiengesellschaft.

Trajectory Similarity
0.72
Similar
Peer-set rank: #1
within Moderna, Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

The match is driven mainly by investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MRNA
Moderna, Inc.
16
Peer-Score
Signal qualityHigh
vs
SDF.DE
K+S Aktiengesellschaft
64
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: MRNA vs SDF.DE Profitability 15 38 Stability 3 58 Valuation 30 68 Growth 9 100 MRNA SDF.DE
Gap Ranking
#1 Growth +91
#2 Stability +55
#3 Valuation +38
#4 Profitability +23
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MRNA and SDF.DE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MRNASDF.DE Relative valuation Structural strength

K+S Aktiengesellschaft looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative valuation score and Forward P/E where available.

Relative Position vs Comparable Companies
Growth
On growth, K+S Aktiengesellschaft ranks near the top of the group; Moderna, Inc. sits in the weaker half.
Stability
On stability, K+S Aktiengesellschaft is positioned higher in the group, while Moderna, Inc. is closer to the middle.
Growth — Dominant Gap
MRNA
9
SDF.DE
100
Gap+91in favour of SDF.DE

One company is still expanding while the other is contracting, which creates a very wide growth split.

What else supports the lead

Stability still reinforces the same direction, which makes the lead look broader across the profile.

What this means for the comparison

The lead is built on both growth and stability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the MRNA vs SDF.DE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-stability comparisons

Explore how MRNA and SDF.DE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.